e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice
Seki M., Yanagihara K., Higashiyama Y., Fukuda Y., Kaneko Y., Ohno H., Miyazaki Y., Hirakata Y., Tomono K., Kadota J., Tashiro T., Kohno S.
Source:
Eur Respir J 2004; 24: 143-149
Journal Issue:
July
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Seki M., Yanagihara K., Higashiyama Y., Fukuda Y., Kaneko Y., Ohno H., Miyazaki Y., Hirakata Y., Tomono K., Kadota J., Tashiro T., Kohno S.. Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J 2004; 24: 143-149
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Protein tyrosine phosphatase 1B negatively regulates S100A9 mediated apoptosis during respiratory syncytial virus infection
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
TLR9- and Src-dependent expression of Krueppel-like factor 4 controls interleukin-10 expression in pneumonia
Source: Eur Respir J 2013; 41: 384-391
Year: 2013
TOLL-like receptors polymorphism in pneumonia associated with influenza A(H1N1)/09
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
Impaired viral clearance after influenza infection in IDO transgenic mice
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Lymphocytes mediate the anti-apoptotic effect of respiratory syncytial virus on human neutrophils
Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity
Year: 2007
Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Nontypeable Haemophilus influenzae infection of human lung tissue induces proinflammatory cytokine response via toll-like receptor 2 and EGF-receptor
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
LATE-BREAKING ABSTRACT: RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013
Dynamics of cortisol, IL-6, and the soluble IL-2 receptor in the severe influenza virus infection
Source: Eur Respir J 2003; 22: Suppl. 45, 516s
Year: 2003
The role of human neutrophil defensins in patients with pneumonia caused by influenza A (H1N1v)
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Inducible epithelial resistance modulates innate antiviral signaling against coronavirus and influenza
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Syk is downstream of ICAM-1 and mediates human rhinovirus (HRV) activation of p38 MAP kinase in airway epithelial cells
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006
Clarithromycin inhibits pandemic A/H1N1/2009 influenza virus infection in human airway epithelial cells
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma
Source: Eur Respir J 2002; 19: 68-75
Year: 2002
RSV and human metapneumovirus – major pathogens of childhood – also adults and the elderly?
Source: Annual Congress 2005 - Major viral threats to the lung
Year: 2005
A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms
Source: Eur Respir J 2008; 31: 725-735
Year: 2008
Influenza type A outbreak associated with myositis
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept